Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities-Reference-Cited by-同舟云学术

Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities

Published:2010-01 Issue:1 Volume:12 Page:93-124
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Comhair Suzy A.A.¹,Erzurum Serpil C.¹

Affiliation:

1. Pathobiology, Lerner Research Institute, and the Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2008.2425

Reference355 articles.

1. Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases

2. Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase

3. Peroxidases Inhibit Nitric Oxide (NO) Dependent Bronchodilation: Development of a Model Describing NO−Peroxidase Interactions

4. Oxidative Stress Induces NFκB DNA Binding and Inducible NOS mRNA in Human Epithelial Cells

5. The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-28

2. Neutralizing Oxidized Phosphatidylcholine Reduces Airway Inflammation and Hyperreactivity in a Murine Model of Allergic Asthma;Biology;2024-08-17

3. YiQi GuBen capsule alleviates OVA-induced asthma through improving mitochondrial dysfunction;Journal of Asthma;2024-04-22

4. Deciphering the Immune Subtypes and Signature Genes: A Novel Approach Towards Diagnosing and Prognosticating Severe Asthma through Interpretable Machine Learning;2024-04-20

5. Targeting Common Inflammatory Mediators in Experimental Severe Asthma and Acute Lung Injury;Pharmaceuticals;2024-03-05